584690AC5
Medicis Pharmaceutical Corporation
Could not find a ticker for this position, may be a filing error
A maker of dermatology and aesthetic treatments, Medicis brought skincare brands like Restylane and Dysport to the US, products widely used by doctors for smoothing wrinkles. Founded in 1988 in Scottsdale, Arizona, by Jonah Shacknai and John Holaday, the company grew by picking up skin, acne, and psoriasis drugs that bigger firms had overlooked. Its name plays on the Latin "medicus," meaning physician or healer, echoing the old Italian Medici family. In 2012 it was acquired by Valeant (now Bausch Health), and those aesthetic brands later passed to Galderma.
NOTEUnderlying: MRXCUSIP: 584690AC5HealthcareUS1 derivative reporter
1.375% Convertible Senior Notes due 2017
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
